Whitepapers/App Notes/Posters

Whitepaper: The necessity of E&L qualifications for lyophilized drug products

Posted: 4 February 2021 | | No comments yet

Lyophilized drug product containers and administration devices consist of the primary packaging, the reconstitution solution container, and the drug administration set.

Lyophilized drug product containers and administration devices consist of the primary packaging (typically a glass vial and a rubber stopper), the reconstitution solution container (typically a vial or a prefilled syringe system), and the drug administration set (such as a disposable syringe, an intravenous bag, or a pump system with administration tubing) as shown in the Whitepaper.











    To read this Whitepaper in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Nelson Labs

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Send this to a friend